| 000 | 02994nam a22004095i 4500 | ||
|---|---|---|---|
| 999 |
_c10477 _d10477 |
||
| 001 | 10477 | ||
| 003 | DE-He213 | ||
| 005 | 20210615040621.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180216s2018 gw | s |||| 0|eng d | ||
| 020 | _a9783319255866 | ||
| 024 | 7 |
_a10.1007/978-3-319-25586-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _dES-VaUE |
||
| 050 | 4 |
_aRC280 _b.B6 2018 EB |
|
| 245 | 1 | 0 |
_aMultiple Myeloma and Other Plasma Cell Neoplasms _cedited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos. |
| 264 | 1 |
_aCham _bSpringer International Publishing : _bImprint: Springer _c2018. |
|
| 300 | _a1 recurso en línea (VI, 245 páginas 14 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto (visual) _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 1 |
_aHematologic Malignancies, _x2197-9766 |
|
| 490 | 0 | _aMedicine (Springer-11650) | |
| 520 | 3 | _aThis book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström’s macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. . | |
| 650 | 7 |
_aMieloma múltiple _9160182 _2embne |
|
| 700 | 1 |
_aDimopoulos, Meletios A. _eeditor literario |
|
| 700 | 1 |
_aFacon, Thierry. _eeditor literario _0http://id.loc.gov/authorities/names/no2002033748 _0http://viaf.org/viaf/37830800 |
|
| 700 | 1 |
_aTerpos, Evangelos. _eeditor literario _0http://id.loc.gov/authorities/names/n2018185161 _0http://viaf.org/viaf/82152380122801761713 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9783319255842 |
| 776 | 0 | 8 |
_iEdición impresa: _z9783319255859 |
| 830 | 0 |
_aHematologic Malignancies, _x2197-9766 _9133681 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-25586-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia) |
| 942 |
_2lcc _cLE |
||
| 998 | _db | ||